Nazli Dizman
@nazlidizman
MD & Researcher | Heme/Onc fellow @MDAndersonNews | @YaleIMed ‘23 | Postdoc @cityofhope @montypal | @ASCOTECAG | #WomenInMedicine | T/RT my own
ID: 733782620958511105
https://coi.asco.org/share/J7C-BSUP/Nazli%20Dizman 20-05-2016 22:13:04
18,18K Tweet
8,8K Followers
5,5K Following
Cheers to Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute & the brilliant team incl James Brugarolas Jaime Merchan Howard Gurney John Haanen et al who contributed to this impt study in Annals of Oncology. Dose finding trials are of critical importance & offer key insights as we have seen in studies of
🧬🚨 Our study on novel antigens induced in glioblastoma upon treatment with epigenetic therapy is out!! This study was led by joshhjang with co-first-authors Yonghao Liang and Ju-Heon Maeng, and mentored by Ting Wang and Albert H. Kim. 5 Key Takeaways: 1/5 nature.com/articles/s4158…
It's with great pleasure that we welcome Dr. Thejal Srikumar to the GI Medical Oncology faculty. She'll focus on early onset GI cancers and cancer genetics. We know you'll do great things!💫 Thejal Srikumar Yale Cancer Center Smilow Cancer Hospital Roy Herbst Eric Winer, MD Center for Gastrointestinal Cancers
🚀 Excited to share that I’ve joined Emory School of Medicine & Winship Cancer Institute of Emory University to launch The Berchuck Lab. Our research is focused on using liquid biopsy to improve outcomes for people living with cancer. We’re hiring for several key roles! Learn more & apply: theberchucklab.org
Join the editors of European Urology and chief editor Alberto Briganti for a lovely talk on how to maximize your abstracts content in anticipation of #EAU25 YUO GURS Society of Urologic Oncology Amer. Urol. Assn. ASCO Sumanta K. Pal, MD, FASCO
A very important and practice-informing trial dealing with HIF2 inhibitor Belzutifan dose in RCC. More is not better ! Congrats Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute and team! Bravo !
It sounds fantastic! Sumanta K. Pal, MD, FASCO is overall brilliant, phenomenal leader, super mentor & so insightful! Looking forward to hearing about the impact of his talk! Neeraj Agarwal, MD, FASCO Toni Choueiri, MD Tanya Dorff OncoAlert Huntsman Cancer Institute Umang Swami Benjamin L Maughan SWOG Cancer Research Network Tian Zhang, MD, MHS Shilpa Gupta
Looking forward to Sumanta K. Pal, MD, FASCO joining us at the University! Come and join the presentation!
A gripping grand round “Gut Bacteria & Cancer: Friend and Foe?” by super investigator Sumanta K. Pal, MD, FASCO. Fascinating to learn about microbiome potential, ways to modulate it including exercise Neli Ulrich, PhD Neeraj Agarwal, MD, FASCO and his IITs with CBM588 & camu-camu
A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman, the new David Goldstein Chair Dana-Farber. The Chair will focus on many aspects of Kidney Cancer Research Dana-Farber Lank Center for Genitourinary Oncology
What an honor to give the #Quagliana Endowed Lectureship at University of Utah/University of Utah Department of Internal Medicine! Many thanks to Neeraj Agarwal, MD, FASCO for the invitation. Beyond the lecture, was delighted to sit in with his research team (Umang Swami Georges Gebrael Benjamin L Maughan Vinay Mathew Thomas Chadi Hage Chehade Zeynep Irem Ozay, MD et al)
Thrilled to have superstar Sumanta K. Pal, MD, FASCO visiting us today at Huntsman Cancer Institute! Great conversations & much learned about 🦠🧫💩!!
Thank you to Society for Immunotherapy of Cancer and Melanoma Research for supporting our research!
I'm incredibly honored & very grateful to my former boss & mentor Robert Z. Orlowski whose guidance and support have been instrumental in my journey. I owe much of this achievement to your leadership and belief in me. Excited for the path ahead as we continue advancing care for MM pts!
There are more than enough women surgeons out there to serve as key opinion leaders, trialists, and experts in the field . Problem is not a leaky pipeline but implicit bias when selecting. JAMA Surgery editor straight to the 🎯
We are honored to participate in tomorrow’s President's Cancer Panel discussion on optimizing clinical care & research workforce and appreciate panel’s commitment to addressing challenges facing the onc workforce & impact on people with cancer. #Every1HasARole brnw.ch/21wMyUi
Just in Journal of Clinical Oncology 👉Final OS analysis of SWOG Cancer Research Network 1500 trial 👉 data support cabozantinib for treatment of advanced papillary RCC #kidneycancer (unless clinical trials are available). Free access paper 👉 tinyurl.com/2s3t7z27 Congrats Pedro C Barata, MD MSc FACP & Sumanta K. Pal, MD, FASCO & authors Naomi Haas
